Although gastric and urothelial carcinomas are quite different in their nature, however, in predicting responses for immunotherapy using PD-L1 IHC, CPS is used in interpretation and both cancers were approved relatively early for immunotherapy. Here, CD274 is linked to urothelial carcinoma.